Search
for

    Sort by

    Research 391–420 of 1000+

    1. Risk factors for prostate cancer: a case‐control study in Greece International Journal of Cancer · 1999 · 14 citations
    2. Poria cocos polysaccharides attenuate chronic nonbacterial prostatitis by targeting the gut microbiota: Comparative study of Poria cocos polysaccharides and finasteride in treating chronic prostatitis International Journal of Biological Macromolecules · 2021 · 12 citations
    3. Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link? 2018 · 12 citations
    4. Recent advances in treatment for Benign Prostatic Hyperplasia F1000Research · 2015 · 12 citations
    5. Chemopr�vention des Prostatakarzinoms Der Urologe · 2004 · 12 citations
    6. A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia Drug safety · 1998 · 12 citations
    7. Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers Cancers · 2022 · 10 citations
    8. The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction Fertility and Sterility · 2021 · 8 citations
    9. The influence of <i>Castanea sativa</i> Mill. flower extract on hormonally and chemically induced prostate cancer in a rat model Food & Function · 2021 · 7 citations
    10. Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth Evidence-based complementary and alternative medicine · 2016 · 6 citations
    11. Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer Medical Oncology · 2013 · 6 citations
    12. Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis Cancers · 2024 · 3 citations
    13. Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia The Journal of Urology · 2017 · 1 citations
    14. Chemoprävention des Prostatakarzinoms - Ein Plädoyer Aktuelle Urologie · 2012 · 1 citations
    15. Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells Therapeutics · 2025
    16. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses PLoS medicine · 2024
    17. Fluxactive Complete (#1 PREMIUM PROSTATE SUPPORT FORMULA) Managing Prostate Wellness And Bladder Functions! Zenodo (CERN European Organization for Nuclear Research) · 2022
    18. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study UNC Libraries · 2020
    19. 5α- Reductase Inhibitors in Prostate Cancer: An Overview Austin Journal of Cancer and Clinical Research · 2017
    20. Photoacoustic imaging for prostate brachytherapy cIRcle (University of British Columbia) · 2014
    21. 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM The Journal of Urology · 2013
    22. Diagnosis and treatment of prostatitis after TURP 国际泌尿系统杂志 · 2011
    23. Finasteride and prostate cancer 2011
    24. Management of Advanced Prostate Cancer Undergoing Major Shift Oncology times · 2011
    25. 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR European Urology Supplements · 2011
    26. Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes Jurnal Natural (Faculty of Mathematics and Natural Science, Syiah Kuala University) · 2010
    27. Urological Oncology: Prostate Cancer 2010
    28. Slow progress in prostate cancer BJUI · 2007
    29. How not to detect prostate cancer Lancet Oncology · 2007
    30. Effects of the androgen receptor overexpression in prostate cancer 2007